Atlas Trials

Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer

Clinical trial NCT02567253 · COMPLETED

Trial details

NCT number
NCT02567253
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian CancerPrimary Peritoneal Cancer
Start date
2016-03-01
Primary completion
2020-12-31
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.